Clinical trial Recruiting at 4 sites Observational Ages 18 and up Women only

60-day peripheral nerve stimulation to reduce pain and improve function after acute thoracolumbar compression fracture

Official title: Effect of 60-day Peripheral Nerve Stimulation (PNS) in Alleviating Pain and Improving Function After Acute Thoracolumbar Compression Fracture

Run by Saint Peters University Hospital · NCT07079865 · Data updated 2026-11-12

This program will try 60-day SPRINT peripheral nerve stimulation in adult women with recent thoracolumbar compression fractures to see if it lowers pain and improves function.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment15 (estimated)
SponsorSaint Peters University Hospital
Academic / other
Locations4 sites (Avenel, New Jersey and 3 other locations)
StatusRecruiting
StartedAugust 7, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedFebruary 18, 2026
Trial IDNCT07079865 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (18+) with primary osteoporosis and an acute or subacute thoracic or lumbar compression fracture within the past three months who report at least moderate pain (NRS ≥4) despite OTC therapies are the ideal candidates.

Probably not a fit

Patients with pathological fractures from malignancy or other non-osteoporotic causes, active infection, untreated coagulopathy, uncontrolled psychosocial illness, or other excluded conditions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adult women with osteoporosis who have thoracic or lumbar compression fractures less than three months old and receive a 60-day SPRINT peripheral nerve stimulation (PNS) implant. Pain (Numeric Rating Scale and Brief Pain Inventory) and patient-reported outcomes (PROMIS via the CareSense digital system) are collected one week before implantation and at 2 weeks, 3 months, and 6 months after implantation. Participants may be taking opioids at baseline but, per routine practice, no additional opioids will be prescribed during the PNS intervention. The primary focus is on short-term pain reduction with secondary analysis of function and quality of life over six months.

Why it matters

Potential benefit: If successful, 60-day PNS could reduce pain and improve daily function and quality of life for women with recent thoracolumbar compression fractures.

How similar studies have gone: Percutaneous short-term PNS systems such as SPRINT have shown pain reductions in other acute and postoperative pain settings, but their use specifically for thoracolumbar compression fractures is relatively new.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult females ages 18+
* Osteoporosis diagnosis with acute/subacute insufficiency fractures of the thoracic or lumbar spine identified on MRI or X-ray with significant pain and activity limitation.
* Onset of pain from associated fracture should be less than 3 months.
* Minimum pain should be 4 or greater (Moderate) on the NRS scale and/or impairing their daily activity.
* Patients reported pain should be despite OTC medication trials of NSAIDs, Tylenol, lidocaine patches or similar medications.
* Patients may be taking opioids while receiving treatment however as per routine practice, no additional opioids will be prescribed during the PNS intervention.

Exclusion Criteria:

* Patients with pathological fractures, other etiologies of fracture such as pagets disease, multiple myeloma, local or systemic infection, untreated coagulopathy, untreated psychosocial disease.
* Other etiologies of osteoporosis other than primary osteoporosis will be excluded such as hyperparathyroidism, anorexia, malabsorption, hyperthyroidism, or overtreatment of hypothyroidism, chronic renal failure, cushing.
* Patients with diminished mental capacity (mental condition that will inhibit their ability to complete the assessments) as determined by the investigator.
* Patients with an active cardiac implant device such as a pacemaker or defibrillator.

Where it's running

  • University Orthopaedic Associates - Division of OrthoNJ
    Avenel, New Jersey, United States
    Recruiting
  • University Orthopaedic Associates - Division of OrthoNJ
    Morganville, New Jersey, United States
    Recruiting
  • University Center for Ambulatory Surgery (UCAS)
    Somerset, New Jersey, United States
    Recruiting
  • University Orthopaedic Associates - Division of OrthoNJ
    Somerset, New Jersey, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.